1Reilly MP,McKenzie SE.Mechanisms of action of IVIG:physiology of Fc receptors.Vox Sang,2002,83(Suppl 1):57-63
2Bussel JB.Fc receptor blockade and immune thrombocytopenic purpura.Semin Hematol,2000,37(3):261-266
3Aktas O,Zipp F.Regulation of self-reactive T cells by human immunoglobulins- implications for multiple sclerosis therapy.Curr Pharm Des,2003,9(3):245-256
4George J,Barshack I,Malka E,et al.The effect of intravenous immunoglobulins on the progression of experimental autoimmune myocarditis in the rat.Exp Mol Pathol,2001,71(1):55-62
5Zhuang Q,Bisotto S,Fixman ED,et al.Suppression of IL-4- and CD40-induced B-lymphocyte activation by intravenous immunoglobulin is not mediated through the inhibitory IgG receptor Fc gammaRIIb.J Allergy Clin Immunol,2002,110 (3):480-483
6Ichiyama T,Yoshitomi T,Nishikawa M,et al.NF-kappaB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease.Clin Immunol,2001,99(3):373-377
7Aukrust P,Muller F,Nordoy I,et al.Modulation of lymphocyte and monocyte activity after intravenous immunoglobulin administration in vivo.Clin Exp Immunol,1997,107(1):50-56
8Mouthon L,Kaveri SV,Spalter SH,et al.Mechanisms of action of intravenous immune globulin in immune-mediated diseases.Clin Exp Immunol,1996,104(Suppl 1):3-9
9Kazatchkine MD,Kaveri SV.Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.N Engl J Med,2001,345 (10):747-755
10Fukunaga E,Kunishige M,Mitsui T,et al.Severe dermatomyositis with rhabdomyolysis and paralytic ileus:a case successfully treated with plasmapheresis and intravenous immunoglobulin.Eur J Neurol,2002,9(6):697-698
